Overview

The Gene Technology Act 2000 was enacted to address the need for a regulatory framework governing the use and potential risks associated with genetically modified organisms (GMOs) within Australia. This Act was introduced by the Commonwealth Parliament to provide a comprehensive regulatory scheme that ensures the protection of human health and the environment while also facilitating the safe and responsible use of gene technology. The policy objective behind this legislation is to manage the risks associated with the import, development, and commercial use of GMOs in a manner that balances innovation and scientific advancement with public safety and environmental protection. In line with this objective, the Act established the Office of the Gene Technology Regulator, which is responsible for assessing applications and ensuring compliance with the regulatory requirements set out in the Act. In October 2022, the Gene Technology Regulator issued a public consultation on the proposed commercial import and distribution of genetically modified chrysanthemums by International Flower Developments Pty Ltd. These GM chrysanthemums have been modified for altered flower colour and are intended for the floral industry, not for human consumption. The Regulator has prepared a Risk Assessment and Risk Management Plan (RARMP) for this application and is seeking written submissions from the public to inform its decision on whether to issue the necessary licence. The public is encouraged to review the RARMP and related information, which can be accessed via the Office of the Gene Technology Regulator’s website, and to submit their feedback by 20 December 2022. This consultation process exemplifies the Act's commitment to transparency and community involvement in the regulation of gene technology.

Scope and Application

The Gene Technology Act 2000 (Cth) applies to the commercial import and distribution of genetically modified (GM) organisms, including the genetically modified chrysanthemums in question. The Act is administered by the Gene Technology Regulator, who is responsible for assessing applications such as the one from International Flower Developments Pty Ltd for GM chrysanthemums altered for flower colour. The Act applies to the entities and individuals involved in the importation and distribution of GM products within Australia, ensuring that any risks to human health and safety and the environment are assessed and managed. The geographic reach of the Act is national, applying across the Commonwealth of Australia. The Act allows for the issuance of licences for the commercial import and distribution of GM products, subject to the terms and conditions outlined in the Risk Assessment and Risk Management Plan. The Regulator’s decision is informed by public submissions and the RARMP, which are available for review and comment prior to the Regulator making a final decision. The Act does not apply to GM organisms intended for human food, as these are subject to separate regulatory controls under the Food Standards Australia New Zealand Act 1991 (Cth).

Key Provisions

The Gene Technology Act 2004 (the Act) governs the assessment and regulation of genetically modified organisms, including the commercial import and distribution of genetically modified plants. The Act is administered by the Gene Technology Regulator, who, in this instance, is evaluating an application from International Flower Developments Pty Ltd for the commercial import and distribution of genetically modified chrysanthemums with altered flower colour (sections 16 and 17). This application is subject to a thorough assessment of risks to human health and safety and the environment, as outlined in the Risk Assessment and Risk Management Plan (RARMP) provided by the Regulator (section 18). The Act imposes several obligations on the applicant, including providing comprehensive information about the genetically modified organism, its potential impacts, and the measures in place to manage any risks (section 21). The applicant must also demonstrate compliance with any conditions set by the Regulator to mitigate identified risks (section 23). Additionally, the applicant is required to maintain records and reports, as specified by the Regulator, to ensure ongoing monitoring and compliance with the Act (section 26). Failure to comply with the Act or the conditions of a licence may result in both civil and criminal consequences. Under the Act, breaches may lead to enforcement actions such as fines, injunctions, or directions to cease activities (section 130). The maximum penalty for serious or repeated breaches can be substantial, with fines reaching up to $2.7 million for corporations and $270,000 for individuals, reflecting the seriousness of non-compliance with the Act’s provisions (section 131). Additionally, criminal charges may be pursued for offences involving wilful or reckless endangerment to human health or the environment (section 134). These penalties underscore the importance of adhering to the legislative requirements and risk management plans established under the Act.